Abstract:Cancer, as a conundrum, is currently the biggest killer of human health. The major viewpoint of carcinogenesis is owing to somatic gene mutations. Based on such a viewpoint and the development of gene sequencing technology, extensive genomic alterations in cancer genomes have been identified. How to develop a better understanding of the link between gene mutations and carcinogenesis as well as efficient clinical cancer therapy is therefore a major challenge. Weinberg and Hanahan have suggested 10 hallmarks of cancer. The hallmarks are highly regulated by the corresponding signaling pathways. Thus, cancer itself is also a disease of dysfunction of signal transduction pathways related to multiple fundamental cell processes, including proliferation, differentiation, apoptosis, invasion and so on. Despite the signaling pathways are extremely complex in cancer cells, one can still focus on the signaling networks that govern the corresponding cell processes for modeling to discuss its dynamics and regulation functions quantitatively. Systems biology provides appropriate approach to integrate the experimental data (clinical data) and signaling pathway for a comprehensive analysis, resulting in a further prediction for optimal therapy and drug discovery. In this paper, we review the recent progress of dynamical modeling of signaling networks by using systems biology approaches that help to exploring the mechanisms of carcinogenesis. We first discuss the motif dynamics of the signaling networks. The presented generic circuit model can be decomposed into two loops and the circuit can achieve tristability through four kinds of bifurcation scenarios when parameter values are varied in a wide range. Then, we show the relative well-studied core signaling networks that regulate the cell survival, apoptosis, proliferation, invasion and energy metabolism processes. For each fundamental cell process, we individually review the dynamics of corresponding signaling network based on the systems biology approaches, including the NF-B signaling pathway that regulates the cell survival process, the Ras signaling pathway that governs the cell proliferation process, the EMT and mitochondrial signaling pathway that modulate the cell invasion and apoptosis processes. Furthermore, two coupled signaling networks, i.e., the p53 and TNF- signaling networks are discussed. Lastly, we review the breast cancer and gastric cancer signaling networks which contain several fundamental cell processes. The potential contribution for cancer treatment is also suggested. These dynamical modeling based on the core signaling networks can facilitate the understanding of the mechanisms of carcinogenesis and provide us the possible clues and ideas of the cancer treatment and drug design. We believe more exciting research works in this field will be stimulated in the near future.

Identification, Modeling and Simulation of Key Pathways Underlying Certain Cancers

Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

Proteomics, Pathway Array and Signaling Network-Based Medicine in Cancer

Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma

A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups

Mathematical and Computational Modeling in Complex Biological Systems

Identifying Dysregulated Pathways in Cancers from Pathway Interaction Networks

A graph-based multi-sample test for identifying pathways associated with cancer progression

The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms

Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data

Identification of Common and Subtype-Specific Mutated Sub-Pathways for a Cancer.

Dynamical Studies of Cellular Signaling Networks in Cancers

Quantification of the underlying mechanisms and relationship among cancer, metastasis and differentiation/development

Identification of breast cancer risk modules via an integrated strategy

Pan-cancer study on transition of signaling systems from primary to metastatic tumors

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Microarray bioinformatics in cancer- a review

Drug Screening and Biomarker Gene Investigation in Cancer Therapy Through the Human Transcriptional Regulatory Network

Identifying Cancer-Related Micrornas Based on Gene Expression Data

Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis

Molecular characteristics and prognostic role of EPHA2 in human tumors via pan-cancer analysis